Funding in private companies in China from January through June was concentrated in medicine and health care, as well as “corona-tech” companies that have developed online solutions in areas such as real estate and education amid the pandemic, according to Chinese startup news site 36Kr, which is in partnership with Nikkei. Investment in artificial intelligence and semiconductors also increased due to the U.S. conflict with China in the high-tech sector.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
